Neuroscience

We are advancing research across several neurologic disorders, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and stroke.

A resilient pursuit to preserve personhood

We are resolute in our commitment to help those living with and affected by the realities of neurologic diseases. We strive to preserve personhood in the face of unrelenting challenges. We stand with patients, their families and healthcare providers to navigate neuroscience’s unchartered frontiers and inevitable setbacks to deliver science that will make a meaningful difference and a remarkable impact on people’s lives.

Living with a Neurodegenerative Disease

The path toward transformational therapies

At AbbVie, we invest in neuroscience research that identifies opportunities to help people who live with neurologic disorders, such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and stroke. We are committed to investing in research that identifies opportunities for real modification, delivering pioneering science, built on inevitable setbacks, that will make a meaningful difference for patients.

Neuroscience research centers

On May 18, 2016, we opened a 43,000-square-foot Cambridge Research Center in Cambridge, Massachusetts. At the Cambridge Research Center, we will undergo research to gain a deeper understanding of the biological mechanisms underlying neurodegenerative diseases.

Take a tour inside

Our focus areas

Learn more about our commitment to help those living with and affected by neurologic diseases.

Alzheimer’s disease
Multiple sclerosis
Parkinson’s disease
Stroke

Delivering science that makes a difference

We invest in research that identifies opportunities for real modification – delivering science that will make a meaningful difference in people’s lives.